Team develops new tool, LumosVar, for discerning genetic variants; more genomic sequencing needed for clinical application to cancer patients PHOENIX and LOS ANGELES — Oct. 26, 2017 — Precision Medicine…
Encouraging early results following timely treatment guided by comprehensive genomic sequencing PHOENIX, Ariz. - Oct. 25, 2017 - Several patients with recurring glioblastoma, a deadly brain cancer, survived for more…
Dr. Waldemar Priebe is a medicinal chemist with an interest in brain tumors, and a drug he discovered and developed is on its way to a clinical trial at MD…
Two studies by researchers at the Translational Genomics Research Institute (TGen) and the University of North Carolina Lineberger Comprehensive Cancer Center (UNC Lineberger) provide insight on the evolution of glioblastoma…
Cancers evolve in rapidly changing environments from single cells into genetically heterogeneous masses. Darwinian evolution selects for survival of the fittest cells, that is, those that are best suited to…
High-grade gliomas are aggressive cancers that often become rapidly fatal. Immunotherapy using CD8+ cytotoxic T lymphocytes (CTLs), engineered to express both herpes simplex virus type 1 thymidine kinase (HSV1-TK) and…
Obesity and type 2 diabetes (T2D) represent some of the most significant public health challenges facing our society. Disparities in obesity and T2D emerge early in life and disproportionately impact…
The survival of patients diagnosed with glioblastoma (GBM), the most deadly form of brain cancer, is compromised by the proclivity for local invasion into the surrounding normal brain, which prevents…
Research is funded by Ivy Foundation Scottsdale, Ariz. (Dec. 9, 2015) – Nicholas Butowski, M.D., has been selected to serve as the principal investigator of the Ivy Foundation Early Phase…
Study funded by Ivy Foundation shows PPF could help treat glioblastomas by sensitizing tumors to chemotherapy and radiation treatments PHOENIX, Ariz. — Nov. 12, 2015 — In a significant breakthrough,…